Results 261 to 270 of about 206,195 (300)

Cold, Hot, and Lethal-The Tumour Microenvironment and the Immunology of Head and Neck Squamous Cell Carcinoma. [PDF]

Int J Mol Sci
Vyhnánková S, Lacina L, Chovanec M, Plzák J, Smetana K, Netušil J, Kolář M, Šindelka R.   +7 more
europepmc   +1 more source

IAP Antagonists Selectively Eliminate Therapy‐Induced Senescent Cancer Cells via TNFα‐Independent Apoptosis

Cancer Science, EarlyView.
Upon chemotherapy, a subset of cancer cells enters a senescent state, referred to as TIS. When IAP antagonists are administered, TIS cells are selectively eliminated through TNFα‐independent apoptosis. TNFα secreted by TIS cancer cells may also act in a paracrine manner to enhance extrinsic apoptosis in neighboring non‐senescent cancer cells.
Hiroaki Ochiiwa, Takeshi Wakasa, Yuki Kataoka, Koji Ando, Eiji Oki, Yoshihiko Maehara, Makoto Iimori, Hiroyuki Kitao   +7 more
wiley   +1 more source

Immunohistochemical expression of inflammasome-related proteins in head and neck squamous cell carcinoma tissues-A systematic review. [PDF]

J Oral Maxillofac Pathol
Prasad H, Kala N, Jacob M, Rajmohan M.
europepmc   +1 more source

CSNK1D inhibition suppresses head and neck squamous cell carcinoma progression through SHH and PTCH1 pathway. [PDF]

Cell Death Dis
Yang L, Li X, Zhu Y, Zhang Y, Liu Z, Lin C, Jiang C, Su YX, Ji T, Wang Y, Gao J, Ye J.   +11 more
europepmc   +1 more source

The immunologic landscape of HRAS-mutant head and neck squamous-cell carcinoma. [PDF]

ESMO Open
Economopoulou P, Rampias T, Spathis A, Kotsantis I, Kyriazoglou A, Anastasiou M, Pantazopoulos A, Gomatou G, Margeli A, Papageorgiou M, Foukas P, Psyrri A.   +11 more
europepmc   +1 more source

Nanoparticle Albumin-Bound Paclitaxel and Nivolumab for PD-1 Inhibitor-Refractory Recurrent or Metastatic Head and Neck Squamous-Cell Carcinoma. [PDF]

Cancer Med
Adkins D, Ley JC, Auberle C, Knapp B, Zaretsky J, Liu J, Oppelt P.   +6 more
europepmc   +1 more source

MicroRNAs as Emerging Therapeutic Targets Modulating the Tumor Microenvironment in Head and Neck Squamous Cell Carcinoma. [PDF]

Int J Mol Sci
Brata RD, Marcut L, Barb AC, Manole A, Ciolofan A, Dumitru CS, Zara F, Patrascu R.   +7 more
europepmc   +1 more source

Trends in the Use of Neoadjuvant Systemic Therapy for Head and Neck Squamous Cell Carcinoma.

JAMA Netw Open
Cai WL, Helou V, Carlson KM, Mazul AL, Zandberg DP, Spector ME, Zevallos JP, Ferris RL, Contrera KJ.   +8 more
europepmc   +1 more source